在2A/IIC型威尔布兰德病中,通过外源性威尔布兰德病的补充来纠正VWF多元化
Ziqi Zhang1, Qian Liang1, Xiaoqian Xu2
1Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China; State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.
Molecular therapy : the journal of the American Society of Gene Therapy
|September 17, 2025
概括
由于基因大小,对·维勒布兰德病 (VWD) 的基因治疗具有挑战性. 在2A/IIC型VWD模型中,在转化恢复的VWF多元化中补充VWF (VWFpp),提供一种新的治疗方法.
科学领域:
- 生物化学 生物化学
- 遗传学 是一个遗传学.
- 血液学 血液学 血液学
背景情况:
- 对于·威尔布兰德病 (VWD) 的基因治疗,由于庞大的·威尔布兰德因子 (VWF) 基因而面临局限性.
- 影响VWF (VWFpp) 的特定VWF变异导致VWF多元化受损,导致2A/IIC型VWD.
研究的目的:
- 调查跨VWFpp补充的潜力,以恢复VWF多元化在VWF变体与有缺陷的propeptides.
- 评估VWFpp补充剂在2A/IIC型VWD小鼠模型中的治疗疗效.
主要方法:
- 野生类型VWFpp与突变的全长VWF在体外共表达,以评估VWF多元体配置文件.
- 开发和处理2A/IIC型VWD的转基因小鼠模型,使用编码VWFpp的AV9载体与内皮特异性促进体.
主要成果:
- 在体外研究显示,在VWFpp同表达后,八种2A/IIC型VWD变异体的VWF多元形状得到了适度但持续的改善.
- 用VWFpp治疗的转基因小鼠显示恢复了VWF多元化,增加了VWF:CB水平 (15.8%至71.2%),纠正了出血倾向,并改善了血小板功能.
- 根据VWFpp缺陷的性质 (D2:D2接口完整性),需要不同的VWFpp级别来进行救援.
结论:
- 在trans VWFpp中,补充有效地纠正了由VWFpp变体引起的VWF多元化缺陷.
- 这种方法为2A型/IIC型VWD提供了一个有前途的新疗法策略,解决了当前基因疗法的关键局限性.
- 该研究强调了VWFpp在VWF多元组件中的关键作用及其作为治疗点的潜力.
相关概念视频
Venous Thrombosis III: Interprofessional Care
280
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
280
Clot Retraction and Fibrinolysis
8.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.5K
Extrinsic and Intrinsic Pathways of Hemostasis
12.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
12.1K
Formation of the Platelet Plug
8.8K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.8K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.7K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.7K
Disorders of Hemostasis
2.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.0K


